Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors

NCT05714748 · clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
19
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

West China Hospital